Cargando…

New markers for human ovarian cancer that link platinum resistance to the cancer stem cell phenotype and define new therapeutic combinations and diagnostic tools

BACKGROUND: Ovarian cancer is the leading cause of gynecologic cancer-related death, due in part to a late diagnosis and a high rate of recurrence. Primary and acquired platinum resistance is related to a low response probability to subsequent lines of treatment and to a poor survival. Therefore, a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Muñoz-Galván, Sandra, Felipe-Abrio, Blanca, García-Carrasco, Miguel, Domínguez-Piñol, Julia, Suarez-Martinez, Elisa, Verdugo-Sivianes, Eva M., Espinosa-Sánchez, Asunción, Navas, Lola E., Otero-Albiol, Daniel, Marin, Juan J., Jiménez-García, Manuel P., García-Heredia, Jose M., Quiroga, Adoración G., Estevez-Garcia, Purificacion, Carnero, Amancio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6547556/ https://www.ncbi.nlm.nih.gov/pubmed/31159852 http://dx.doi.org/10.1186/s13046-019-1245-5

Ejemplares similares

Downregulation of MYPT1 increases tumor resistance in ovarian cancer by targeting the Hippo pathway and increasing the stemness
por: Muñoz-Galván, Sandra, et al.
Publicado: (2020)

c‐MYB‐ and PGC1a‐dependent metabolic switch induced by MYBBP1A loss in renal cancer
por: Felipe‐Abrio, Blanca, et al.
Publicado: (2019)

Loss of MYBBP1A Induces Cancer Stem Cell Activity in Renal Cancer
por: Felipe-Abrio, Blanca, et al.
Publicado: (2019)

Mutation of SPINOPHILIN (PPP1R9B) found in human tumors promotes the tumorigenic and stemness properties of cells
por: Verdugo-Sivianes, Eva M, et al.
Publicado: (2021)

Coordinated downregulation of Spinophilin and the catalytic subunits of PP1, PPP1CA/B/C, contributes to a worse prognosis in lung cancer
por: Verdugo-Sivianes, Eva M., et al.
Publicado: (2017)

A new treatment for sarcoma extracted from combination of miRNA deregulation and gene association rules
por: García-Heredia, José Manuel, et al.
Publicado: (2023)

Sarcoma stratification by combined pH2AX and MAP17 (PDZK1IP1) levels for a better outcome on doxorubicin plus olaparib treatment
por: Perez, Marco, et al.
Publicado: (2020)

Numb-like (NumbL) downregulation increases tumorigenicity, cancer stem cell-like properties and resistance to chemotherapy
por: García-Heredia, José M., et al.
Publicado: (2016)

Role of the Holoenzyme PP1-SPN in the Dephosphorylation of the RB Family of Tumor Suppressors During Cell Cycle
por: Verdugo-Sivianes, Eva M., et al.
Publicado: (2021)

Breast tumor cells promotes the horizontal propagation of EMT, stemness, and metastasis by transferring the MAP17 protein between subsets of neoplastic cells
por: García-Heredia, José Manuel, et al.
Publicado: (2020)

The Tumor Suppressor Roles of MYBBP1A, a Major Contributor to Metabolism Plasticity and Stemness
por: Felipe-Abrio, Blanca, et al.
Publicado: (2020)

NAD pool as an antitumor target against cancer stem cells in head and neck cancer
por: Navas, Lola E., et al.
Publicado: (2023)

Empty spiracles homeobox genes EMX1 and EMX2 regulate WNT pathway activation in sarcomagenesis
por: Jimenez-García, Manuel Pedro, et al.
Publicado: (2021)

Regulation of sarcomagenesis by the empty spiracles homeobox genes EMX1 and EMX2
por: Jimenez-García, Manuel Pedro, et al.
Publicado: (2021)

Cellular senescence or stemness: hypoxia flips the coin
por: Otero-Albiol, Daniel, et al.
Publicado: (2021)

Chronotherapy: Circadian Rhythms and Their Influence in Cancer Therapy
por: Amiama-Roig, Ana, et al.
Publicado: (2022)

MAP17 (PDZK1IP1) and pH2AX are potential predictive biomarkers for rectal cancer treatment efficacy
por: Rivero, Maria, et al.
Publicado: (2018)

NAMPT overexpression induces cancer stemness and defines a novel tumor signature for glioma prognosis
por: Lucena-Cacace, Antonio, et al.
Publicado: (2017)

NAD(+) metabolism, stemness, the immune response, and cancer
por: Navas, Lola E., et al.
Publicado: (2021)

Nicotinamide Adenine Dinucleotide (NAD) Metabolism as a Relevant Target in Cancer
por: Navas, Lola E., et al.
Publicado: (2022)

High casein kinase 1 epsilon levels are correlated with better prognosis in subsets of patients with breast cancer
por: Lopez-Guerra, Jose Luis, et al.
Publicado: (2015)

Decoding Warburg's hypothesis: tumor-related mutations in the mitochondrial respiratory chain
por: Garcia-Heredia, Jose M., et al.
Publicado: (2015)

Dr. Jekyll and Mr. Hyde: MAP17’s up-regulation, a crosspoint in cancer and inflammatory diseases
por: García-Heredia, José M., et al.
Publicado: (2018)

The cargo protein MAP17 (PDZK1IP1) regulates the immune microenvironment
por: García-Heredia, José M., et al.
Publicado: (2017)

NUMB and NUMBL differences in gene regulation
por: García-Heredia, José Manuel, et al.
Publicado: (2018)

Role of Mitochondria in Cancer Stem Cell Resistance
por: García-Heredia, José Manuel, et al.
Publicado: (2020)

A Six-Gene Prognostic and Predictive Radiotherapy-Based Signature for Early and Locally Advanced Stages in Non-Small-Cell Lung Cancer
por: Peinado-Serrano, Javier, et al.
Publicado: (2022)

Implications of maraviroc and/or rapamycin in a mouse model of fragility
por: Pérez-Martínez, Laura, et al.
Publicado: (2020)

Cellular Senescence as a Target in Cancer Control
por: Vergel, Mar, et al.
Publicado: (2010)

Efficacy of bortezomib in sarcomas with high levels of MAP17 (PDZK1IP1)
por: Perez, Marco, et al.
Publicado: (2016)

MAP17 and SGLT1 Protein Expression Levels as Prognostic Markers for Cervical Tumor Patient Survival
por: Perez, Marco, et al.
Publicado: (2013)

MAP17 predicts sensitivity to platinum-based therapy, EGFR inhibitors and the proteasome inhibitor bortezomib in lung adenocarcinoma
por: Ferrer, Irene, et al.
Publicado: (2018)

New Findings in the Signaling Pathways of cis and trans Platinum Iodido Complexes’ Interaction with DNA of Cancer Cells
por: Quiroga, Adoración G., et al.
Publicado: (2019)

NAMPT as a Dedifferentiation-Inducer Gene: NAD(+) as Core Axis for Glioma Cancer Stem-Like Cells Maintenance
por: Lucena-Cacace, Antonio, et al.
Publicado: (2019)

PDGFRα/β and VEGFR2 polymorphisms in colorectal cancer: incidence and implications in clinical outcome
por: Estevez-Garcia, Purificacion, et al.
Publicado: (2012)

Therapeutic Targeting of Signaling Pathways Related to Cancer Stemness
por: Espinosa-Sánchez, Asunción, et al.
Publicado: (2020)

Senotherapeutics in Cancer and HIV
por: Sánchez-Díaz, Laura, et al.
Publicado: (2022)

Gene expression profile predictive of response to chemotherapy in metastatic colorectal cancer
por: Estevez-Garcia, Purificacion, et al.
Publicado: (2015)

Efficacy of CDK4 inhibition against sarcomas depends on their levels of CDK4 and p16ink4 mRNA
por: Perez, Marco, et al.
Publicado: (2015)

Targeting Cancer Stem Cells to Overcome Therapy Resistance in Ovarian Cancer
por: Muñoz-Galván, Sandra, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_t6t2nmvv8ajas0v35554uqttui